$56 Million is the total value of Valliance Asset Management Ltd's 9 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 137.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $30,460,778 | +16.0% | 298,109 | 0.0% | 54.39% | +46.1% | |
| BILI | New | BILIBILI INCspons ads rep z | $10,660,634 | – | 453,644 | +100.0% | 19.04% | – |
| FUTU | New | FUTU HLDGS LTDspon ads cl a | $4,719,128 | – | 91,015 | +100.0% | 8.43% | – |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $3,686,848 | -63.4% | 39,635 | -70.7% | 6.58% | -53.9% |
| New | YS BIOPHARMA CO LTDordinary shares | $2,571,480 | – | 1,607,175 | +100.0% | 4.59% | – | |
| HTHT | New | H WORLD GROUP LTDsponsored ads | $2,247,447 | – | 45,885 | +100.0% | 4.01% | – |
| GOTU | GAOTU TECHEDU INCsponsored ads | $1,510,081 | +78.8% | 357,839 | 0.0% | 2.70% | +125.3% | |
| New | YS BIOPHARMA CO LTD*w exp 03/15/202 | $116,775 | – | 750,000 | +100.0% | 0.21% | – | |
| HHLAWS | New | HH&L ACQUISITION CO*w exp 02/04/202 | $28,000 | – | 400,000 | +100.0% | 0.05% | – |
| BZ | Exit | KANZHUN LIMITEDsponsored ads | $0 | – | -51,470 | -100.0% | -1.49% | – |
| BIDU | Exit | BAIDU INCspon adr rep a | $0 | – | -31,800 | -100.0% | -5.16% | – |
| HHLAU | Exit | HH&L ACQUISITION COunit 99/99/9999 | $0 | – | -800,000 | -100.0% | -11.48% | – |
| SMIHU | Exit | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $0 | – | -1,000,000 | -100.0% | -14.35% | – |
| JD | Exit | JD.COM INCspon adr cl a | $0 | – | -186,200 | -100.0% | -14.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HH&L ACQUISITION CO | 8 | Q4 2022 | 100.0% |
| SUMMIT HEALTHCRE ACQUISTN CO | 7 | Q4 2022 | 55.2% |
| PINDUODUO INC | 4 | Q4 2021 | 55.8% |
| TAIWAN SEMICONDUCTOR MFG LTD | 3 | Q2 2023 | 63.9% |
| YS BIOPHARMA CO LTD | 3 | Q3 2023 | 35.4% |
| YS BIOPHARMA CO LTD | 3 | Q3 2023 | 0.6% |
| HH&L ACQUISITION CO | 3 | Q3 2023 | 0.1% |
| ALIBABA GROUP HLDG LTD | 2 | Q1 2023 | 54.4% |
| SEA LTD | 2 | Q3 2021 | 42.3% |
| NVIDIA CORPORATION | 2 | Q3 2023 | 23.0% |
View Valliance Asset Management Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-31 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-04-25 |
| 13F-HR | 2022-01-28 |
| 13F-HR | 2021-10-27 |
View Valliance Asset Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.